Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
about
Induction of PD-L1 expression by epidermal growth factor receptor-mediated signaling in esophageal squamous cell carcinoma.COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status.Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models.Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma.Immune checkpoint therapy in liver cancer.SIRT6 haploinsufficiency induces BRAF melanoma cell resistance to MAPK inhibitors via IGF signallingHistone deacetylase 6 in cancerSilencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
P2860
Q37650062-21DD1F10-AF1E-41B0-A86A-8CF93094C6E7Q37663388-016C73E3-0713-438E-9ADC-06E4BF51D05DQ47271622-A1D70A5C-C3E3-4AFE-9E45-1BFB80CB8538Q48610578-9BEA2638-6A10-42C7-B545-0EA652BFB68CQ50066085-7F61714A-F828-4E49-B54F-D109047EC899Q50147664-EBD27E6D-CF2C-4076-A628-C6EB6026B0FCQ55008806-B64ADFFA-B5A4-4088-8FEE-35E4B3509EB4Q57010854-AC43C4E2-5CF9-48F6-9C3A-E693EA2758E4Q58768571-4CAEF468-0778-47A9-BFD1-9E0D9A0E4F97Q59137904-BABA029B-03E9-444F-9B56-2F13452C8DD1
P2860
Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
@en
type
label
Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
@en
prefLabel
Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
@en
P2093
P2860
P1433
P1476
Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
@en
P2093
Kozikowski A
Montecino M
Perez-Villarroel P
Pinilla-Ibarz J
P2860
P304
P356
10.1016/J.MOLONC.2015.12.012
P577
2016-01-06T00:00:00Z